Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Evaluate in parallel the efficacy of 2 different Tarceva-containing regimens as first-line therapy measured as the percentage of patients that have progressed at 6 months among stage IIIB/IV NSCLC patients selected on the basis of EGFR protein overexpression and/or increased EGFR gene copy numbers.
Critère d'inclusion
- non-small cell lung cancer